Global Cold Atmospheric Plasma Therapy Equipment Market Insights and Future Outlook 2026-2032

The global Cold Atmospheric Plasma Therapy Equipment market was valued at US$ 153 million in 2025 and is anticipated to reach US$ 490 million by 2032, at a CAGR of 18.4% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cold Atmospheric Plasma Therapy Equipment competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Global sales of cold atmospheric plasma therapy equipment reached 12,484 units in 2025, with an average price of US$12,277 per unit.

Cold atmospheric plasma therapy equipment is a device that generates low-temperature, non-thermal equilibrium plasma at ambient pressure and temperature by ionizing a gas (such as helium, argon, or air) through a high-voltage electric field. It contains a large number of electrons, ions, free radicals, reactive oxygen/nitrogen groups, and ultraviolet light, enabling it to act on the body using these physical and chemical factors without burning tissue.

The core raw materials for cold atmospheric plasma therapy equipment include high-purity inert gases (helium or argon, 99.99% or higher, used in jet-type equipment), precision electrodes and dielectric materials (tungsten needles/stainless steel electrodes, quartz glass tubes, alumina ceramic dielectric layers), high-voltage/radio frequency power supply systems (kV-level pulse or MHz-level radio frequency power supplies and impedance matching devices), and medical-grade structural components (biocompatible plastic shells, Teflon gas tubing). For radiofrequency surgical equipment, disposable saline irrigation tubing and plasma tip electrode consumables are also required.

In terms of cost structure, the equipment exhibits characteristics of "high R&D amortization and small-to-medium batch production": Initial R&D investment in plasma physics and medical safety verification is substantial (accounting for 40-60% of initial costs); the core high-voltage power supply and precision gas control module (mostly imported) account for 30-40% of hardware costs; and medical-grade certification (CE/FDA/NMPA) and clinical trial fees further increase unit costs. During the operation phase, the continuous consumption of helium constitutes the main consumable expense (jet equipment consumes several liters per hour), resulting in a single treatment gas cost reaching tens of yuan.

The North American market for Cold Atmospheric Plasma Therapy Equipment is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Cold Atmospheric Plasma Therapy Equipment is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Cold Atmospheric Plasma Therapy Equipment include Apyx Medical Corporation, ADTEC Plasma Technology, Neoplas med GmbH, Terraplasma Medical GmbH, CINOGY System GmbH, D.B SkinTech, US Medical Innovations, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Cold Atmospheric Plasma Therapy Equipment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cold Atmospheric Plasma Therapy Equipment. The Cold Atmospheric Plasma Therapy Equipment market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cold Atmospheric Plasma Therapy Equipment market comprehensively. Regional market sizes by Type, by Application, by Discharge Principles, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Cold Atmospheric Plasma Therapy Equipment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Discharge Principles, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Cold Atmospheric Plasma Therapy Equipment manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.

Chapter 3: Examines Cold Atmospheric Plasma Therapy Equipment sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.

Chapter 7: Reviews the industry value chain, including upstream and downstream segments.

Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 9: Summarizes the key findings and conclusions of the report.